What is Breathe Diagnostics?
Breathe Diagnostics specializes in advanced sleep study and EEG services, catering to individuals with various sleep disorders and neurological conditions. The company offers comprehensive diagnostic sleep studies and home EEG testing, aiming to provide convenient and accessible high-quality, cost-effective care across Southern California. Their operational focus is on compassionate patient engagement and building robust partnerships within the healthcare community.
How much funding has Breathe Diagnostics raised?
Breathe Diagnostics has raised a total of $357K across 2 funding rounds:
Debt
$150K
Debt
$207K
Debt (2020): $150K with participation from PPP
Debt (2021): $207K led by PPP
Key Investors in Breathe Diagnostics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Breathe Diagnostics?
The substantial late-stage funding indicates Breathe Diagnostics is poised for significant expansion and further development of its diagnostic capabilities. This capital infusion is expected to fuel strategic initiatives, potentially including market penetration into new regions, enhancement of technological infrastructure for sleep and EEG services, and the cultivation of deeper clinical research partnerships. The company's trajectory suggests a strong emphasis on scaling operations and solidifying its position as a leader in accessible neurological and sleep disorder diagnostics.
See full Breathe Diagnostics company page
